UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Psychopharmacology, 2020-08, Vol.237 (8), p.2485-2497

2020

Volltextzugriff (PDF)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Psychopharmacology, 2019-09, Vol.236 (9), p.2735-2745

2019

Volltextzugriff (PDF)

MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?

Progress in neuro-psychopharmacology & biological psychiatry, 2018-06, Vol.84 (Pt A), p.221-228

2018

Volltextzugriff (PDF)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

The Lancet. Psychiatry, 2018-06, Vol.5 (6), p.486-497

2018

Volltextzugriff (PDF)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

Scientific reports, 2020-11, Vol.10 (1), p.20442-20442, Article 20442

2020

Volltextzugriff (PDF)

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Journal of psychopharmacology (Oxford), 2011-04, Vol.25 (4), p.439-452

2011

Volltextzugriff (PDF)

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

Journal of psychopharmacology (Oxford), 2018-12, Vol.32 (12), p.1295-1307

2018

Volltextzugriff (PDF)

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Psychopharmacology, 2021-02, Vol.238 (2), p.581-588

2021

Volltextzugriff (PDF)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Journal of psychopharmacology (Oxford), 2013-01, Vol.27 (1), p.28-39

2013

Volltextzugriff (PDF)

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder

European journal of psychotraumatology, 2024, Vol.15 (1), p.2297536-2297536

2024

Volltextzugriff (PDF)

Progress and promise for the MDMA drug development program

Psychopharmacology, 2018-02, Vol.235 (2), p.561-571

2018

Volltextzugriff (PDF)

Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Psychopharmacology, 2024-08

2024

Volltextzugriff (PDF)

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline

Frontiers in psychiatry, 2019-09, Vol.10, p.650-650

2019

Volltextzugriff (PDF)

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA

The Lancet. Psychiatry, 2016-05, Vol.3 (5), p.481-488

2016

Volltextzugriff (PDF)

The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD

Medical hypotheses, 2021-01, Vol.146, p.110367-110367, Article 110367

2021

Volltextzugriff (PDF)

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy

Journal of psychopharmacology (Oxford), 2017-08, Vol.31 (8), p.967-974

2017

Volltextzugriff (PDF)

Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example

Journal of psychoactive drugs, 2019-04, Vol.51 (2), p.166-173

2019

Volltextzugriff (PDF)

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

European journal of psychotraumatology, 2020-12, Vol.11 (1), p.1840123-1840123

2020

Volltextzugriff (PDF)

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Psychopharmacology, 2024-08

2024

Volltextzugriff (PDF)

RETRACTED ARTICLE: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Psychopharmacology, 2021-02, Vol.238 (2), p.581-588

2021

Volltextzugriff (PDF)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD

Frontiers in psychiatry, 2021-06, Vol.12, p.702838-702838

2021

Volltextzugriff (PDF)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder

Journal of traumatic stress, 2021-08, Vol.34 (4), p.851-863

2021

Volltextzugriff (PDF)

Post-Traumatic Stress Disorder

The New England journal of medicine, 2017-11, Vol.377 (18), p.1796

2017

Volltextzugriff (PDF)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil

Revista brasileira de psiquiatria, 2021-03, Vol.43 (2), p.181-185

2021

Volltextzugriff (PDF)

Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Psychopharmacology, 2024-08

2024

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(93)
Bücher
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(70)
Psychiatry
(28)
Plant Sciences
(27)
Humans
(26)
Mdma
(26)
Psychotherapy
(24)
Ptsd
(23)
Ecstasy
(17)
Biochemistry & Molecular Biology
(15)
Post Traumatic Stress Disorder
(15)
Neurosciences
(13)
Adults
(12)
Animals
(12)
Jasmonic Acid
(12)
Neurosciences & Neurology
(12)
Stress Disorders, Post-Traumatic - Drug Therapy
(12)
Treatment Outcome
(12)
Adult
(11)
Male
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder

Progress and promise for the MDMA drug development program

Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA

The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy

Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

RETRACTED ARTICLE: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder

Post-Traumatic Stress Disorder

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil

Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Suchergebnisse filtern